HTLV-1 associated myelopathy in Canada.

HTLV-1 associated myelopathy in Canada.

We report the clinical and laboratory findings of six Canadian patients with progressive myelopathy associated with HTLV-1 infection. The diagnosis was suspected on clinical grounds and supported by serological studies and positive gene amplification. Only five had emigrated from an area endemic for...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Power, C, Weinshenker, BG, Dekaban, G, Ebers, G, Francis, G, Rice, G
Formato:	Journal article
Idioma:	English
Publicado em:	1989

Registros relacionados

ABSENCE OF ANTIBODIES TO HTLV-I AND HTLV-III IN SERA OF PATIENTS WITH MS AND CHRONIC MYELOPATHY
por: Rice, G, et al.
Publicado em: (1986)

Some clinical and pathologic observations on chronic myelopathy: a variant of multiple sclerosis.
por: Weinshenker, BG, et al.
Publicado em: (1990)

Absence of antibody to HTLV I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy.
por: Rice, G, et al.
Publicado em: (1986)

Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy.
por: Kevin G Buell, et al.
Publicado em: (2016-01-01)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis.
por: Kirk, P, et al.
Publicado em: (2011)

Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy.
por: Felipe von Glehn, et al.
Publicado em: (2012-01-01)

Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy
por: Tomoo Sato, et al.
Publicado em: (2024-10-01)

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
por: Weinshenker, BG, et al.
Publicado em: (1992)

Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.
por: Weinshenker, BG, et al.
Publicado em: (1989)

B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy
por: Aowei Lv, et al.
Publicado em: (2024-10-01)

Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
por: Antonio Mastino, et al.
Publicado em: (2011-05-01)

Magnetic resonance imaging in HTLV-I associated myelopathy
por: Aílton Melo, et al.
Publicado em: (1993-09-01)

HTLV-I associated myelopathy in salvador (northeastern Brazil)
por: A. Meireles, et al.
Publicado em: (1992-06-01)

Galvanic vestibular stimulation for the postural rehabilitation of HTLV-1-associated myelopathy
por: Tatiana Rocha Silva, et al.
Publicado em: (2024-12-01)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Alvaro Schwalb, et al.
Publicado em: (2020-06-01)

Diffusion tensor imaging metrics in diagnosis of HTLV‐1‐associated myelopathy
por: Sheila N. F. Liberato de Matos, et al.
Publicado em: (2022-04-01)

Dermatologic Manifestations in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Reza Boostani, et al.
Publicado em: (2019-05-01)

Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis
por: Naiane Araújo Patrício, et al.
Publicado em: (2020-11-01)

Systemic interferon alfa in multiple sclerosis.
por: Weinshenker, BG, et al.
Publicado em: (1989)

The natural history of multiple sclerosis.
por: Weinshenker, BG, et al.
Publicado em: (1987)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Satoshi Nozuma, et al.
Publicado em: (2017-04-01)

An open trial of OKT3 in patients with multiple sclerosis.
por: Weinshenker, BG, et al.
Publicado em: (1991)

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
por: Jeffery, K, et al.
Publicado em: (1999)

Immunologic parameters of cerebrospinal fluid in HTLV-I associated myelopathy
por: Marzia Puccioni-sohler
Publicado em: (1995-06-01)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Taylor Graham P, et al.
Publicado em: (2011-06-01)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Stumpf Michael PH, et al.
Publicado em: (2011-10-01)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
por: Satoshi Nozuma, et al.
Publicado em: (2016-01-01)

Cognitive impairment in HTLV-1-associated myelopathy, proviral load and inflammatory markers
por: Ana Paula Silva Champs, et al.
Publicado em: (2019-07-01)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene
por: Antonio C. R. Vallinoto, et al.
Publicado em: (2015-01-01)

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy
por: Akihito Koseki, et al.
Publicado em: (2023-06-01)

HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients
por: Rosa Maria do Nascimento Marcusso, et al.
Publicado em: (2024-05-01)

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
por: Marco Baratella, et al.
Publicado em: (2017-01-01)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Yoshimi Enose-Akahata, et al.
Publicado em: (2019-11-01)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Overlapping Ossification of the Ligamentum Flavum
por: Guilherme Gago, et al.
Publicado em: (2020-09-01)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
por: Reza Boostani, et al.
Publicado em: (2016-05-01)

Caracterização molecular do HTLV-1 em pacientes com paraparesia espástica tropical/mielopatia associada ao HTLV-1 em Belém, Pará Molecular characterization of HTLV-1 among patients with tropical spastic paraparesis/HTLV-1 associated myelopathy in Belém, Pará
por: Lucinda A. Souza, et al.
Publicado em: (2006-10-01)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Houshang Rafatpanah, et al.
Publicado em: (2013-03-01)

Use of Oral Corticosteroids to Treat HTLV-1-Associated Myelopathy (HAM) in São Paulo, Brazil
por: Flavia Esper Dahy, et al.
Publicado em: (2023-05-01)

Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients
por: Larissa Deadame de Figueiredo Nicolete, et al.
Publicado em: (2012-09-01)

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
por: Shuntaro Tsutsumi, et al.
Publicado em: (2019-10-01)